Clinical Trial Update: Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating clinical, imaging, and biologic markers to identify progression in Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Ken Marek, MD | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED